Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 17th August 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product recall for Ketofen 10% Solution for Injection
Veterinary surgeons, retailers and wholesale dealers are asked to examine inventory.
Visual inspection confirmed possibility of particulate contamination. 

Ceva Animal Health has recalled Ketofen 10% Solution for Injection.

The Class II recall was initiated after a visual inspection confirmed a possibility of particulate contamination, which is unacceptable for an intravenous use preparation. 

Only the following batches have been recalled:
    •   108AB Expiry 12/02/2023
    •   113H Expiry 16/03/2023

Veterinary surgeons, retailers and wholesale dealers are being contacted and told to examine inventory immediately, and then quarantine any products subject to recall. 

Ketofen 10% Solution for Injection is used to treat cattle, horses and other equidae, and pigs, and is a non-narcotic, non-steroidal anti-inflammatory agent with analgesic and anti-pyretic properties. 

Anyone with further questions on the recall is advised to contact Peter Kyte on +44 1494 781510 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.